國家衛生研究院 NHRI:Item 3990099045/6119
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 860852      線上人數 : 933
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/6119


    題名: International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18
    作者: Chie, WC;Blazeby, JM;Hsiao, CF;Chiu, HC;Poon, RT;Mikoshiba, N;Al-Kadhimi, G;Heaton, N;Calara, J;Collins, P;Caddick, K;Costantini, A;Vilgrain, V;Trinquart, L;Chiang, C
    貢獻者: Division of Clinical Trial Statistics
    摘要: This international field validation study examined the psychometric properties and clinical validity of the European Organisation for Research and Treatment of Cancer (EORTC) questionnaire module for hepatocellular carcinoma, the EORTC QLQ-HCC18. The EORTC QLQ-HCC18 was administered with the core questionnaire, the EORTC QLQ-C30 to 272 patients from seven centres in six countries. Patient acceptability of the module was examined with a debriefing questionnaire and psychometric and clinical properties were assessed. Multi-trait scaling analyses confirmed the hypothesised scale structure without any scaling error and the fatigue scale demonstrated satisfactory internal consistency. The test-retest reliability scores were high for all scales except abdominal swelling and sexual interest. The correlations between of all scales of the QLQ-HCC18 and the QLQ-C30 were low or moderate and many scales could distinguish patients with different clinical conditions. The module demonstrated responsiveness to clinical change in pain before and after surgery and some borderline change in patients undergoing systemic treatment. Conclusion: The EORTC QLQ-HCC18 can be used as a supplementary module for the EORTC QLQ-C30 in clinical trials for patients with HCC.
    日期: 2012-04
    關聯: Hepatology. 2012 Apr;5(4):1122-1129.
    Link to: http://dx.doi.org/10.1002/hep.24798
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0270-9139&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000302069900015
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84859155440
    顯示於類別:[蕭金福] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PB2011120603.pdf458KbAdobe PDF405檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋